Bunaprolast (U-66858) is a potent inhibitor of leukotriene B4 (LTB4); it also inhibits lipoxygenase and thromboxane B2 (TXB2) release. It exhibits significant inhibition of thromboxane A2 release in comparative studies with the cyclooxygenase (COX) inhibitor flurbiprofen. In vivo, Bunaprolast demonstrates dose-related inhibition of airway resistance (RL) and dynamic compliance (Cdyn) changes in IgE-mediated hypersensitivity responses to Ascaris antigen in rhesus primates when administered orally, and shows dose-independent inhibition when delivered via aerosol.